🔗 Share this article

While the United States proceeds with unprecedented changes to its immunization guidelines, a particular individual has emerged unexpectedly: Høeg, a Danish American sports physician and public health researcher who first made her name by expressing skepticism about Covid vaccinations during the pandemic and has focused upon potential deaths following Covid immunization in her short tenure at the FDA.

Proposed Changes to Childhood Immunization Schedule

Health officials planned to reveal radical revisions to the childhood immunization program earlier this month, aligning the US with the Danish immunization schedule, it is understood – a significant shift that would put the US out of step with many the global community with little proof for public health gain. The planned update has been delayed until the coming year.

Instead of the top vaccines chief, Tracy Beth Høeg is scheduled to address the audience at the meeting. She was newly appointed interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to lead the center this year.

A Shift at the Agency

The acting appointment may indicate a strengthened alliance between the pharmaceutical and biologics divisions as Dr. Høeg and Prasad consolidate power at the regulatory agency – and it signals a greater focus upon dismantling previously authorized vaccines at the FDA.

Høeg has often pushed for halting certain pediatric shot schedules in the US so as to align more like the Danish model, a nation with nationalized medicine and a citizenry about the population of the state of Wisconsin.

In her initial comments, she has continued to focus on immunizations – typically the responsibility of Prasad, chief of the FDA’s CBER – rather than medication approval.

Doubts Over Background

Høeg has little discernible background in drug development, oversight or administrative roles, which has been customary for former heads of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a top consultant to the commissioner and the vaccine center since March.

“She doesn’t seem to have the necessary background” for leading the CDER, stated a neurologist and psychiatrist. “She lacks experience running a scientific study. She has no expertise in leading a large organization. She lacks background in pharmaceutical oversight.”

Past heads of CBER would “grasp legal statutes and the underlying principles of medication creation”, commented Dr. Janet Woodcock. “Frankly, she lacks the sort of resume that prior appointees who led the center have had.”

CDER has an vast range of responsibilities at the FDA, she pointed out.

“Everybody just pays attention on the novel medication approvals, but the generic program clears numerous generic drugs. There’s a biosimilars program, OTC medication office and other areas, and all of those have to be managed,” Woodcock noted. “The area you neglect, that’s the thing that I always told people is going to bite you.”

Furthermore, a significant leadership element to the position, which supervises in excess of 5,000 staff members. “It’s a enormous leadership role, if you do it right,” she concluded.

Response and Contentious Policies

When asked about questions about Høeg’s credentials and whether this assignment indicates greater collaboration among FDA leaders on vaccines, a representative stated that the “questions are based on incorrect premises”.

“Her resume aligns with the responsibilities of her job,” the spokesperson stated, noting the months Høeg spent guiding the agency head on “medication safety and approval science, including predictive safety algorithms and vaccine surveillance”.

As acting director, Dr. Høeg takes over the agency head's recently launched fast-track approval initiative, a controversial rapid therapy clearance system that reportedly worried her predecessors. “By what process are these therapies being selected for this voucher program? Who takes the choices?” Dr. Howard questioned. “There’s a lot of confidentiality happening at the regulatory body right now.”

In general, he remarked, “the agency appears to be shifting towards less stringent oversight of all drugs, with the exception of vaccines.”

Established History on Vaccines

With immunizations, Høeg has a clearer, if problematic, track record, some experts have noted. She released a analysis using non-validated public submissions to determine the rate of heart inflammation after COVID-19 immunization. She consulted for the Florida chief medical officer Dr. Joseph Ladapo, who allegedly have altered data to imply Covid vaccines are more dangerous than they are.

Part of her “desired changes” for the current administration featured changing guidelines for recently developed shots and ending “unnecessary” vaccines, she stated post-election on a online show. At the agency, Høeg has allegedly suggested preventing adolescent males from receiving COVID-19 vaccines.

“She is an all-around dogmatist who begins with her conclusions and tailors the evidence to fit the science in a extremely deceptive, fraudulent way,” Dr. Howard said.

Consolidating Power and a “Campaign of Retribution”

Dr. Høeg aligned with other dissenters, {like|